A Geographic Variant of theStaphylococcus aureusPanton‐Valentine Leukocidin Toxin and the Origin of Community‐Associated Methicillin‐ResistantS. aureusUSA300
Open Access
- 15 January 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (2) , 187-194
- https://doi.org/10.1086/524684
Abstract
Background. The majority of recent community-associated methicillin-resistant Staphylococcus aureus (MRSA) infections in the United States have been caused by a single clone, USA300. USA300 secretes Panton-Valentine leukocidin (PVL) toxin, which is associated with highly virulent infections. Methods. We sequenced the PVL genes of 174 S. aureus isolates from a global clinical sample. We combined phylogenetic reconstruction and protein modeling methods to analyze genetic variation in PVL. Results. Nucleotide variation was detected at 12 of 1726 sites. Two PVL sequence variants, the R variant and the H variant, were identified on the basis of a substitution at nt 527. Of sequences obtained in the United States, 96.7% harbor the R variant, whereas 95.6% of sequences obtained outside the United States harbor the H variant; 91.3% of MRSA isolates harbor the R variant, and 91.3% of methicillin-susceptible strains harbor the H variant. A molecular model of PVL shows 3 mechanisms by which the amino acid substitution may affect PVL function. Conclusions. All sampled PVL genes appear to share a recent common ancestor and spread via a combination of clonal expansion and horizontal transfer. US isolates harbor a variant of PVL that is strongly associated with MRSA infections. Protein modeling reveals that this variant may have functional significance. We propose a hypothesis for the origin of USA300.Keywords
This publication has 39 references indexed in Scilit:
- Methicillin-ResistantS. aureusInfections among Patients in the Emergency DepartmentNew England Journal of Medicine, 2006
- Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Genotype as a Major Cause of Health Care--Associated Blood Stream InfectionsClinical Infectious Diseases, 2006
- Characterization of a Strain of Community-AssociatedMethicillin-Resistant Staphylococcus aureus WidelyDisseminated in the UnitedStatesJournal of Clinical Microbiology, 2006
- Inducible Clindamycin Resistance and Molecular Epidemiologic Trends of Pediatric Community-Acquired Methicillin-Resistant Staphylococcus aureus in Dallas, TexasAntimicrobial Agents and Chemotherapy, 2005
- Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin GenesClinical Infectious Diseases, 2005
- Natural History of Community‐Acquired Methicillin‐ResistantStaphylococcus aureusColonization and Infection in SoldiersClinical Infectious Diseases, 2004
- Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the CommunityJournal of Clinical Microbiology, 2002
- Community‐Acquired Methicillin‐ResistantStaphylococcus aureusInfections in France: Emergence of a Single Clone That Produces Panton‐Valentine LeukocidinClinical Infectious Diseases, 2002
- Genome and virulence determinants of high virulence community-acquired MRSAThe Lancet, 2002
- "Celbenin" - resistant StaphylococciBMJ, 1961